LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter

The Lyme Disease Network receives a commission from for each purchase originating from this site.

When purchasing from, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive

The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » General Support » Nastiness from Forbes again

 - UBBFriend: Email this page to someone!    
Author Topic: Nastiness from Forbes again
Frequent Contributor (5K+ posts)
Member # 2020

Icon 1 posted      Profile for Ann-OH     Send New Private Message       Edit/Delete Post   Reply With Quote 
If this doesn't make you angry, you are a saint! Forbes doesn't generate any respect with this guy on their payroll.

Go to the website if you would like to write a comment on this article or contact Forbes to let them know what you think of this writer.

There are quite a few good comments there already.

Ann - OH

Alternative Lyme Disease Doctors Are Still Wrong
April 23, 2010 - 10:26 am

David WhelanBio | Email
David Whelan is a staff writer at Forbes

The Infectious Diseases Society of America yesterday released the results of its year-long assessment of its 2006 Lyme disease treatment guidelines. The specialty society was forced, under very unusual circumstances, by Connecticut Attorney General Richard Blumenthal, to hire an outside group of doctors to review its guidelines for possible inaccuracies, bias or conflicts of interest. The verdict: the guidelines, which advise Lyme patients to take short courses of oral antibiotics, are fine the way they are.

Activists and self-anointed Lyme doctors had complained that the IDSA's guidelines were keeping insurance companies from paying for costly long-term courses of infused antibiotics to treat patients suffering from so-called "chronic Lyme disease."

The IDSA, comprised of doctors with advanced training in the treatment of infectious diseases like Lyme, pointed out that such infusions can kill or seriously hurt patients while creating drug-resistant bacteria that threaten the rest of us. One example from the New England Journal of Medicine: a study of infused antibiotics was cut short after Lyme sufferers with persistent symptoms did not respond to a course of antibiotics any better than they did to a placebo. One patient getting antibiotics had a pulmonary embolism; another had gastrointestinal bleeding.

Blumenthal pandered to a vocal group of Connecticut activists, by taking the unprecedented step of "investigating" a group of doctors' treatment guidelines--and forcing the settlement. It was as if a prosecutor threatened to sue the American Academy of Pediatrics over its vaccine schedule to the cheers of Jenny McCarthy-led autism activists. Many IDSA doctor-members were disappointed that the group didn't stand up for science in the courtroom and instead agreed to the review.

Alternative Lyme groups that have and always will promote expensive, potentially dangerous courses of long-term antibiotics are predictably upset and--much like the vaccines = autism crowd after the latest debunking--in complete denial. (See here.)

Blumenthal, who is currently running a much-maligned campaign for U.S. Senate, put out a petulant press release saying his office would review the IDSA's review. (Yesterday's release had none of the flair of the one announcing the results of his investigation back in 2008.)

We wrote about doctors profiting from dubious Lyme treatments back in 2007.


Posts: 5705 | From Ohio | Registered: Jan 2002  |  IP: Logged | Report this post to a Moderator
Honored Contributor (25K+ posts)
Member # 12673

Icon 1 posted      Profile for Keebler     Send New Private Message       Edit/Delete Post   Reply With Quote 
So sad. I have never wished anyone get lyme so that they might better understand. But with this latest turn of events, I sure do wish they'd all have long nightmares where they could get a clue about this.

I'd wish the disease on those who don't get it but they would not be the only ones who would suffer - their family members would, too. But, really if my wishes could come true, lyme would not even exit. Oh, wait, that's what this guy is saying. Maybe he'd trade me places.

Who's paying David Whelan's salary? He obviously has not read the ILADS research or talked with patients who did better with proper treatment. Can we all visit his office? His boss?

Had he been one of my journalism students, his article would have received a failing grade for lack of research.

Posts: 48021 | From Tree House | Registered: Jul 2007  |  IP: Logged | Report this post to a Moderator

Quick Reply

HTML is not enabled.
UBB Code is enabled.

Instant Graemlins

Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:

Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3

The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA

| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.